In this paper, IQVIA Technologies' experts, Karen Maduschke and Vinita Navadgi highlight how a feature-rich electronic consent platform can simplify complex trial designs by reducing the endless stream of consent forms that add time, costs, and risks to each study. Learn how an expertly designed eConsent platform can support master protocol and novel trial designs while improving patient engagement along the way.
Combine data science, technology, and analytics driven by artificial intelligence to support new efficiencies and business insights -- without additional capital investment.
Ease the burden on your sites and make it easier and more appealing for patients to enroll and remain engaged.
Technology informed by unparalleled Decentralized Trials (DCT) operational experience and delivered at global scale.
Deliver eConsent to sites and study participants around the globe with confidence
